As of 4:00pm ET
| +2.51 / +5.81%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 50.00, with a high estimate of 61.00 and a low estimate of 44.00. The median estimate represents a +9.34% increase from the last price of 45.73.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.